false 0001858028 0001858028 2024-07-17 2024-07-17 0001858028 NOVVU:UnitsEachConsistingOfOneOrdinaryShareParValue0.0001PerShareOneRedeemableWarrantEntitlingHolderToPurchaseOneHalfOfOrdinaryShareAndOneRightEntitlingHolderToReceiveOnetenthOfOrdinaryShareMember 2024-07-17 2024-07-17 0001858028 NOVVU:OrdinarySharesMember 2024-07-17 2024-07-17 0001858028 NOVVU:WarrantsMember 2024-07-17 2024-07-17 0001858028 us-gaap:RightsMember 2024-07-17 2024-07-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

July 17, 2024

Date of Report (Date of earliest event reported)

 

Nova Vision Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

 

British Virgin Islands   001-40713   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

2 Havelock Road #07-12

Singapore

  059763
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +65 87183000

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Ordinary Share, par value $0.0001 per share, one Redeemable Warrant entitling the holder to purchase one half of an Ordinary Share, and one Right entitling the holder to receive one-tenth of an Ordinary Share   NOVVU   NASDAQ Capital Market
Ordinary Shares   NOVV   NASDAQ Capital Market
Warrants   NOVVW   NASDAQ Capital Market
Rights   NOVVR   NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

Item 1.01 Entry into a Material definitive Agreement.

 

Amendment to the Agreement and Plan of Merger

 

As previously disclosed, on March 27, 2023, Nova Vision Acquisition Corp., a British Virgin Islands business company (“NOVA” or “Parent”), entered into that certain Agreement and Plan of Merger (the “Merger Agreement”), by and between NOVA and Real Messenger Holdings Limited, a Cayman Islands exempted company (the “Company”). On June 29, 2023, Real Messenger Corporation, a Cayman Islands exempted company wholly owned subsidiary of Parent (“Purchaser”), RM2 Limited, a Cayman Islands exempted company and a wholly owned subsidiary of Purchaser (“Merger Sub”), Nova and the Company executed that certain Joinder Agreement to the Merger Agreement (the “Joinder Agreement”), whereby each of Purchaser and Merger Sub has agreed, effective upon execution, that it shall become a party to the Merger Agreement and shall be fully bound by, and subject to, all of the covenants, terms, representations, warranties, rights, obligations and conditions of the Merger Agreement as though an original party thereto. On August 15, 2023, October 27, 2023, March 7, 2024 and May 29, 2024, respectively, the parties to the Merger Agreement, including Purchaser and Merger Sub, entered into an Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4, respectively, to the Merger Agreement.

 

On July 17, 2024, the parties entered into an Amendment No. 5 to the Merger Agreement (the “Amendment No. 5”). Pursuant to the Amendment No. 5, among other things, the parties agreed that the Closing Payment Shares (as defined in the Merger Agreement) will be increased to 6,400,000 ordinary shares of Purchaser.

 

IMPORTANT NOTICES

 

Important Notice Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains certain “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended. Statements that are not historical facts, including statements about the pending transactions described above, and the parties’ perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the transactions. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated.

 

 
 

 

Such risks and uncertainties include, but are not limited to: (i) risks related to the expected timing and likelihood of completion of the pending transaction, including the risk that the transaction may not close due to one or more closing conditions to the transaction not being satisfied or waived, such as regulatory approvals not being obtained, on a timely basis or otherwise, or that a governmental entity prohibited, delayed or refused to grant approval for the consummation of the transaction or required certain conditions, limitations or restrictions in connection with such approvals; (ii) risks related to the ability of NOVA and the Company to successfully integrate the businesses; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the applicable transaction agreements; (iv) the risk that there may be a material adverse change with respect to the financial position, performance, operations or prospects of the NOVA or the Company; (v) risks related to disruption of management time from ongoing business operations due to the proposed transaction; (vi) the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of NOVA’s securities; (vii) the risk that the proposed transaction and its announcement could have an adverse effect on the ability of the Company to retain dealers and retain and hire key personnel and maintain relationships with their dealers and product users and on their operating results and businesses generally; (viii) the risk that the combined company may be unable to achieve cost-cutting synergies or it may take longer than expected to achieve those synergies; and (ix) risks associated with the financing of the proposed transaction. A further list and description of risks and uncertainties can be found in the Prospectus dated August 5, 2021 relating to NOVA’s initial public offering and in the Registration Statement and proxy statement that has been filed with the SEC by Purchaser in connection with the proposed transactions, and other documents that the parties may file or furnish with the SEC, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and NOVA, the Company and their subsidiaries undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

 

Additional Information and Where to Find It

 

In connection with the transaction described herein, NOVA and and/or its subsidiary will file relevant materials with the Securities and Exchange Commission (the “SEC”), including the Registration Statement on Form F-4 and a proxy statement (the “Registration Statement”). The proxy statement and a proxy card will be mailed to shareholders as of a record date to be established for voting at the stockholders’ meeting of NOVA shareholders relating to the proposed transactions. Shareholders will also be able to obtain a copy of the Registration Statement and proxy statement without charge from NOVA. The Registration Statement and proxy statement, once available, may also be obtained without charge at the SEC’s website at www.sec.gov or by writing to NOVA at 2 Havelock Road #07-12, Singapore. INVESTORS AND SECURITY HOLDERS OF NOVA ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE TRANSACTIONS THAT NOVA WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NOVA, THE COMPANY AND THE TRANSACTIONS DESCRIBED HEREIN.

 

Participants in Solicitation

 

NOVA, the Company and certain shareholders of NOVA, and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from the holders of NOVA ordinary shares stock in respect of the proposed transaction. Information about NOVA’s directors and executive officers and their ownership of NOVA ordinary shares is set forth in the Registration Statement filed by the Purchaser with the SEC. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement pertaining to the proposed transaction when it becomes available. These documents can be obtained free of charge from the sources indicated above.

 

 
 

 

No Offer or Solicitation

 

This Current Report on Form 8-K is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the transactions described above and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of NOVA or the Company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

 

Item 9.01. Financial Statements and Exhibits.

 

EXHIBIT NO.   DESCRIPTION
10.1   Amendment No. 5 to the Merger Agreement dated July 17, 2024 by and among Nova Vision Acquisition Corp, Real Messenger Corporation, RM2 Limited and Real Messenger Holdings Limited*
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 18, 2024

 

NOVA VISION ACQUISITION CORP.  
     
By: /s/ Eric Ping Hang Wong  
Name:  Eric Ping Hang Wong  
Title: Chief Executive Officer  

 

 

 

Exhibit 10.1

 

AMENDMENT No. 5 TO AGREEMENT AND PLAN OF MERGER

 

This Amendment No. 5 dated as of July 17, 2024 (“Amendment 5”) is to amend the Agreement and Plan of Merger (the “Original Merger Agreement”) which was made and entered into as of March 27, 2023, and modified by a Joinder Agreement dated as of June 29, 2023 (the “Joinder”), and amended by Amendment 1 to the Original Merger Agreement dated as of August 15, 2023 (“Amendment 1”), Amendment 2 to the Original Merger Agreement dated as of October 27, 2023 (“Amendment 2”), Amendment 3 to the Original Merger Agreement dated as of March 7, 2024 (“Amendment 3”) and Amendment 4 to the Original Merger Agreement dated as of May 29, 2024 (“Amendment 4”), by and among Nova Vision Acquisition Corp., a British Virgin Islands business company (“Parent”), Real Messenger Holdings Limited a Cayman Islands exempted company (the “Company”), Real Messenger Corporation, a Cayman Islands exempted company and wholly owned subsidiary of the Parent (“Purchaser”) and RM2 Limited, a Cayman Islands exempted company and wholly owned subsidiary of Purchaser (“Merger Sub”). The Original Merger Agreement as amended by the Joinder and by Amendment 1, Amendment 2, Amendment 3 and Amendment 4 is referred to herein as the “Existing Merger Agreement.” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Existing Merger Agreement.

 

Recitals

 

WHEREAS, pursuant to Section 13.2(a) of the Existing Merger Agreement, the Existing Merger Agreement may be amended by a writing signed by each of the Purchaser Parties and the Company; and

 

WHEREAS, the Purchaser Parties and the Company desire to amend the Existing Merger Agreement to reflect the changes agreed between the parties and to clarify certain terms and conditions set forth therein.

 

NOW, THEREFORE, in consideration of the mutual covenants and promises set forth in this Amendment, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1. Amendment of Certain Provisions.

 

(a) Definitions: The following definitions in Article I of the Existing Merger Agreement are amended as follows:

 

The definition of “Convertible Notes” in Article I is hereby amended in its entirety to read as follows:

 

“ ‘Convertible Notes’ means (a) the Company’s Note Series 2023A Notes dated as of October 4, 2023, in the aggregate principal amount of up to $20,000,000, which are automatically convertible into Company Class A Purchaser Ordinary Shares immediately prior to the Closing at a rate of one (1) Company Class A Purchaser Ordinary Share for every $10.00 principal amount of such notes, for an aggregate of 500,000 Class A Purchaser Shares upon their full conversion; as of July 16, 2024, the aggregate amount of Convertible Note Series 2023A issued and outstanding is $5,000,000; and (b) the Company’s Note Series 2024A Notes dated as of July 9, 2024, in the aggregate principal amount of up to $7,000,000, which are automatically convertible into Company Class A Purchaser Ordinary Shares immediately prior to the Closing at a rate of one (1) Company Class A Purchaser Ordinary Share for every $5.00 principal amount of such notes, for an aggregate of 1,400,000 Class A Purchaser Shares upon their full conversion; as of July 16, 2024, the aggregate amount of Convertible Note Series 2024A issued and outstanding is $7,000,000.”

 

 
 

 

The defined term “Closing Payment Shares” is hereby amended in its entirety to read as follows:

 

“ ‘Closing Payment Shares’ means Five Million Seven Hundred Sixty Thousand (5,760,000) Purchaser Ordinary Shares, valued at $10.00 per share.”

 

The defined term “Merger Consideration” is hereby amended in its entirety to read as follows:

 

“ ‘Merger Consideration’ means Sixty-Four Million Dollars ($64,000,000), in the form of Six Million Four Hundred Thousand (6,400,000) Purchaser Ordinary Shares valued at Ten Dollars ($10.00) each. The Merger Consideration will be payable in a combination of Class B Purchaser Ordinary Shares and Class A Purchaser Ordinary Shares, as further provided in Section 4.2(b) hereof and Annex A hereto.”

 

(b) Section 4.1(a):

 

Section 4.1(a) is hereby amended in its entirety to read as follows:

 

“4.1 Conversion of Shares.

 

(a) Conversion of Company Ordinary Shares. At the Effective Time, by virtue of the Acquisition Merger and without any action on the part of Parent, Purchaser, Merger Sub, the Company or the Shareholders, the Company Ordinary Shares (other than the Excluded Shares and Dissenting Shares) issued and outstanding immediately prior to the Effective Time shall be canceled and automatically converted into the right to receive, without interest, the applicable number of Purchaser Ordinary Shares for such number of Company Ordinary Shares as is specified in this Agreement and in Schedule A. The Merger Consideration shall be comprised of two elements, namely: (i) the Closing Payment Shares comprising Five Million Seven Hundred Sixty Thousand (5,760,000) Purchaser Ordinary Shares, which shall be issued and paid to the Shareholders at the Closing; and (ii) an additional Six Hundred Forty Thousand (640,000) Purchaser Ordinary Shares, which shall be issued to the Shareholders at the Closing and held back as security for the Company’s representations and warranties as further set forth in Article XI (the “Holdback Shares”). All Purchaser Ordinary Shares issued as Merger Consideration shall be valued at ten dollars ($10.00) per share.”

 

 
 

 

(c) Section 4.2(b):

 

Section 4.2(b) is hereby amended in its entirety to read as follows:

 

“(b): Issuance of Purchaser Ordinary Shares. As of the Closing Date, Purchaser shall issue an aggregate of six million four hundred thousand (6,400,000) Purchaser Ordinary Shares (comprised of 2,800,000 Class A Purchaser Ordinary Shares and 3,600,000 Class B Purchaser Ordinary Shares as provided herein), which amount represents the sum of (i) the Closing Payment Shares (5,950,000) and (ii) the Holdback Shares (450,000). At the Closing, Purchaser shall deliver the Closing Payment Shares to the Shareholders (in such denominations and proportions as are provided in Schedule A) and shall retain the Holdback Shares (also referred to as the “Exchange Fund”). Purchaser shall pay all or a portion of the Holdback Shares in accordance with the terms of this Agreement. In the event that any Holdback Shares are surrendered back to Purchaser for indemnity obligations, the Holdback Shares so surrendered shall be cancelled by Purchaser. The Exchange Fund shall not be used for any other purpose other than as contemplated by this Agreement.”

 

(e) Section 5.5:

 

Section 5.5 is hereby amended in its entirety to read as follows:

 

“5.5 Capitalization.

 

(a) The authorized share capital of the Company is US$50,000.00 divided into 500,000,000 Company Ordinary Shares, comprised of 496,000,000 Class A Ordinary Shares, of which 1,000,000 are issued and outstanding as of the date hereof, and 4,000,000 Class B Ordinary Shares, of which 4,000,000 are issued and outstanding as of the date hereof. In addition, 1,900,000 Class A Ordinary Shares have been reserved for issuance upon the conversion of the Convertible Notes. All of the issued and outstanding Company Ordinary Shares have been duly authorized and validly issued, are fully paid and non-assessable, and are not subject to any preemptive rights and have not been issued in violation of any preemptive or similar rights of any Person. As of the date hereof, all of the issued and outstanding Company Ordinary Shares are owned legally and beneficially by the Persons set forth on Part 1 of Schedule A, and immediately prior to the Closing, all of the issued and outstanding Company Ordinary Shares will be owned legally and beneficially by the Persons set forth on Part 2 of Schedule A, as the same may be amended no later than one Business Day prior to the Closing. The only Company Ordinary Shares that will be issued and outstanding immediately after the Closing will be the Company Ordinary Shares owned by Purchaser. Except for the Company Ordinary Shares, no other class in the share capital of the Company is or ever has been authorized or issued or outstanding.

 

(b) Except as set forth in Annex A, footnote 5, there are no (a) outstanding subscriptions, options, warrants, rights (including phantom stock rights), calls, commitments, understandings, conversion rights, rights of exchange, restricted stock agreements, plans or other agreements of any kind providing for the purchase, issuance or sale of any Company Ordinary Shares; or (b) to the knowledge of the Company, agreements with respect to any of the Company Ordinary Shares, including any voting trust, other voting agreement or proxy with respect thereto. The holders of the Convertible Notes, and their ownership thereof, are set forth on Annex A.”

 

(g) Schedule A:

 

Schedule A is hereby amended in its entirety to read as set forth in Annex A hereto.

 

 
 

 

2. Miscellaneous.

 

(a) Except as expressly provided in this Amendment, the Existing Merger Agreement shall remain in full force and effect, and all references to “this Agreement,” “herein” or using similar terms in the Existing Merger Agreement shall mean the Existing Merger Agreement as further amended by this Amendment. In the event of a conflict between the terms of this Amendment and the Existing Merger Agreement, the terms of this Amendment shall prevail over and supersede the conflicting terms in the Existing Merger Agreement.

 

(b) Section 9.6 (Confidentiality), Section 13.1 (Notices), Section 13.5 (Publicity), Section 13.8 (Governing Law), Section 13.9 (Waiver of Jury Trial), and Section 13.10 (Submission to Jurisdiction) of the Existing Merger Agreement shall apply to this Amendment mutatis mutandis as if set out herein.

 

(c) This Amendment may be executed in any number of counterparts, each of which will be deemed an original, but all of which together will constitute but one and the same instrument. This Amendment will become effective when duly executed and delivered by each of the parties hereto. Counterpart signature pages to this Amendment may be delivered by electronic delivery (i.e., by email of a PDF signature page) and each such counterpart signature page will constitute an original for all purposes.

 

[The remainder of this page intentionally left blank; signature pages to follow]

 

 
 

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment No 2. to be effective as of the date first written above.

 

  PARENT:
   
  Nova Vision Acquisition Corp., a British Virgin Islands business company
     
  By: /s/ Eric Ping Hang Wong
  Name: Eric Ping Hang Wong
  Title: Chief Executive Officer
     
  COMPANY:
   
  Real Messenger Holdings Limited, a Cayman Islands exempted company
     
  By: /s/ Kwai Hoi Ma
  Name: Kwai Hoi Ma
  Title: Managing Director and CEO
     
  PURCHASER:
   
  Real Messenger Corporation, a Cayman Islands exempted company
     
  By: /s/ Eric Ping Hang Wong
  Name: Eric Ping Hang Wong
  Title: Director
     
  MERGER SUB:
   
  RM2 Limited, a Cayman Islands exempted company
     
  By: /s/ Eric Ping Hang Wong
  Name: Eric Ping Hang Wong
  Title: Director

 

 
 

 

ANNEX A

 

SCHEDULE A—SHAREHOLDER INFORMATION

 

Part 1 – Shareholders of the Company as of the Signing Date

 

Please refer to attached spreadsheet under the heading “Real Messenger Holdings.”

 

Part 2 – Shareholders of the Company as of July 17, 2024

 

Part 3 – Shareholders of the Company as of the Closing Date

 

Please refer to attached spreadsheet under the heading “Real Messenger Holdings – RMSG.”

 

 

v3.24.2
Cover
Jul. 17, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 17, 2024
Entity File Number 001-40713
Entity Registrant Name Nova Vision Acquisition Corp.
Entity Central Index Key 0001858028
Entity Incorporation, State or Country Code D8
Entity Address, Address Line One 2 Havelock Road
Entity Address, Address Line Two #07-12
Entity Address, Country SG
Entity Address, Postal Zip Code 059763
City Area Code +65
Local Phone Number 87183000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units, each consisting of one Ordinary Share, par value $0.0001 per share, one Redeemable Warrant entitling the holder to purchase one half of an Ordinary Share, and one Right entitling the holder to receive one-tenth of an Ordinary Share  
Title of 12(b) Security Units, each consisting of one Ordinary Share
Trading Symbol NOVVU
Security Exchange Name NASDAQ
Ordinary Shares  
Title of 12(b) Security Ordinary Shares
Trading Symbol NOVV
Security Exchange Name NASDAQ
Warrants  
Title of 12(b) Security Warrants
Trading Symbol NOVVW
Security Exchange Name NASDAQ
Rights [Member]  
Title of 12(b) Security Rights
Trading Symbol NOVVR
Security Exchange Name NASDAQ

Nova Vision Acquisition (NASDAQ:NOVVU)
過去 株価チャート
から 11 2024 まで 12 2024 Nova Vision Acquisitionのチャートをもっと見るにはこちらをクリック
Nova Vision Acquisition (NASDAQ:NOVVU)
過去 株価チャート
から 12 2023 まで 12 2024 Nova Vision Acquisitionのチャートをもっと見るにはこちらをクリック